Old | New | Differences | |
---|---|---|---|
1 | 1 | ||
2 | 2 | ||
3 | 3 | LCO No. 2320 1 of 1 | |
4 | 4 | ||
5 | 5 | General Assembly Proposed Bill No. 5714 | |
6 | 6 | January Session, 2025 | |
7 | 7 | LCO No. 2320 | |
8 | 8 | ||
9 | 9 | ||
10 | 10 | Referred to Committee on PUBLIC HEALTH | |
11 | 11 | ||
12 | 12 | ||
13 | 13 | Introduced by: | |
14 | 14 | REP. ANDERSON, 62nd Dist. | |
15 | 15 | ||
16 | 16 | ||
17 | 17 | ||
18 | 18 | AN ACT REQUIRING THE PROVISION OF WRITTEN INFORMATION | |
19 | 19 | BY PHARMACISTS CONCERNING THE EFFECTS OF MIFEPRISTONE | |
20 | 20 | WHEN DISPENSING TO A PATIENT. | |
21 | 21 | Be it enacted by the Senate and House of Representatives in General | |
22 | 22 | Assembly convened: | |
23 | 23 | ||
24 | 24 | That the general statutes be amended to require pharmacists that are 1 | |
25 | 25 | dispensing mifepristone to a patient for the purposes of terminating a 2 | |
26 | 26 | pregnancy to provide written information that its effects may, in some 3 | |
27 | 27 | cases, be reversed if the patient decides to continue with the pregnancy 4 | |
28 | 28 | and seeks reversal treatment in a timely manner. 5 | |
29 | 29 | Statement of Purpose: | |
30 | 30 | To protect reproductive rights in cases where a woman decides to | |
31 | 31 | continue with a pregnancy. |